Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Active Pharmaceutical Ingredients (API) Market to Surpass USD 351.81 Billion Valuation by 2031, High Demand for Effective Therapeutics and Drugs Driving Market Development | SkyQuest Technology

This image opens in the lightbox

News provided by

SkyQuest Technology

15 Jul, 2024, 14:25 GMT

Share this article

Share toX

Share this article

Share toX

WESTFORD, Mass., July 15, 2024 /PRNewswire/ -- According to SkyQuest, the global Active Pharmaceutical Ingredients (API) Market size was valued at USD 210.01 Billion in 2022 and is poised to grow from USD 222.4 Billion in 2023 to USD 351.81 Billion by 2031, growing at a CAGR of 5.9% in the forecast period (2024-2031).

High investments in the research and development of novel pharmaceutical products and high demand for novel active pharmaceutical ingredients are also estimated to bolster market growth. Emphasis on improving active pharmaceutical ingredients manufacturing capabilities will create new opportunities for market players in the future. The global active pharmaceutical ingredients market is segmented into type, synthesis, drug, potency, therapeutic applications, end user, and region.

Download a detailed overview:

https://www.skyquestt.com/sample-request/active-pharmaceutical-ingredients-market

Active Pharmaceutical Ingredients (API) Market Overview:

Report Coverage

Details

Market Revenue in 2023

$ 222.4 billion

Estimated Value by 2031

$ 351.81 billion

Growth Rate

Poised to grow at a CAGR of 5.9%

Forecast Period

2024–2031

Forecast Units

Value (USD Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Type, Synthesis, Drug, Potency, Therapeutic Applications and End User

Geographies Covered

North America, Europe, Asia Pacific, Middle East & Africa, Latin America

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

Demand for high-potency active pharmaceutical ingredients for more effective treatment

Key Market Drivers

Rising prevalence of oncology and cardiovascular indications around the world is driving market growth as APIs are used to develop their therapeutics

Segments covered in Active Pharmaceutical Ingredients (API) Market are as follows:

  • Type
    • Generic APIs, and Innovative APIs
  • Synthesis
    • Synthetic APIs (Generic APIs, Innovative APIs), Biotech (Type {Generic APIs and Innovative APIs}, Product {Monoclonal Antibodies, Hormones, Cytokines, Recombinant Proteins, Therapeutic Enzymes, Vaccines, and Blood Factors}, Expression Systems {Mammalian Expression System, Microbial Expression System, Yeast Expression System, Insect Expression System, Others})
  • Drug
    • Prescription, and Over-the-Counter Drugs (OTC)
  • Potency
    • Traditional APIs, and High Potency APIs
  • Therapeutic applications
    • Communicable Diseases, Oncology, Cardiovascular Diseases, Orthopaedic, Cardiology, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Others
  • End-User
    • Pharmaceutical and Biotechnological Industry, Contact Research Organization, Contract Manufacturing Organization, Others

Request Free Customization of this report:

https://www.skyquestt.com/speak-with-analyst/active-pharmaceutical-ingredients-market

Low Costs of Synthetic API Manufacturing is Pushing Most Companies Towards their Adoption

Synthetic active pharmaceutical ingredients are highly popular and used by pharmaceutical and biotechnology companies owing to their high affordability. High demand for generics and increasing emphasis on improving the affordability of drugs and pharmaceuticals are also expected to help this segment generate rewarding business opportunities. Contract development and manufacturing organizations and pharmaceutical manufacturing companies are projected to lead the demand for synthetic active pharmaceutical ingredients going forward.

Meanwhile, the demand for biotech active pharmaceutical ingredients is forecasted to increase at a staggering CAGR across the study period. High investments in biopharmaceutical industry and innovation of new molecules by the same are also expected to help this segment generate new opportunities for active pharmaceutical ingredients companies in the long run.

High Prevalence of Cardiovascular Disorders to Promote the Demand for Active Pharmaceutical Ingredients in Cardiovascular Therapeutic Applications

Rising need for better security and compliance management in commercial settings to comply with modern regulations. Commercial active pharmaceutical ingredients are being used to manage financial transactions and ledgers of companies to balance the books and keep a record of receivables and payables. Management of accounts is highly crucial for companies and commercial organizations to optimize their business and profitability in the future. Meanwhile, the surging demand for better oncology treatments to manage the rising incidence of cancer cases is also forecasted to present new opportunities for active pharmaceutical ingredients providers in the future.

View report summary and Table of Contents (TOC): 

https://www.skyquestt.com/report/active-pharmaceutical-ingredients-market

Increasing Accessibility to Over-the-counter Drugs and Medications to Offer Lucrative Market Growth Potential

Growing availability of generic over-the-counter (OTC) medications around the world is projected push the demand for active pharmaceutical ingredients over the coming years. Increasing awareness regarding efficacy of OTC medications and their rising adoption among the general population are also anticipated to create new business scope for active pharmaceutical ingredients providers through 2031. 

From new to established, all active pharmaceutical ingredients companies have equal opportunity to succeed in this market. Collaborating with leading pharmaceutical and biotechnology companies will be highly crucial for all active pharmaceutical ingredients market players.

Related Reports:

Active Ingredients Market

Pharmaceuticals Market

Pharmaceutical Intermediates Market

Pharmaceutical Excipients Market

Pharmaceutical Manufacturing Market

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.

Contact:
Mr. Jagraj Singh
SkyQuest Technology
1 Apache Way,
Westford,
Massachusetts 01886
USA (+1) 351-333-4748
Email: sales@skyquestt.com
Visit Our Website: https://www.skyquestt.com/

Logo: https://mma.prnewswire.com/media/2446095/SkyQuest_Logo.jpg

Modal title

Also from this source

Fuel Cell Market: Innovations in Hydrogen Storage Drive 27.1% CAGR by 2031 | SkyQuest Technology

Fuel Cell Market: Innovations in Hydrogen Storage Drive 27.1% CAGR by 2031 | SkyQuest Technology

According to SkyQuest, the global Fuel Cell Market size was valued at USD 2.90 Billion in 2022 and is poised to grow from USD 3.69 Billion in 2023 to ...

Remote Patient Monitoring Market to Hold Substantial Growth with a Striking 16.3% CAGR Mounting Demand for Health Monitoring Devices and Growing Elderly Population are the Main Propellers | SkyQuest Technology

Remote Patient Monitoring Market to Hold Substantial Growth with a Striking 16.3% CAGR Mounting Demand for Health Monitoring Devices and Growing Elderly Population are the Main Propellers | SkyQuest Technology

According to SkyQuest, the global Remote Patient Monitoring Market size was valued at USD 1.9 Billion in 2022 and is poised to grow from USD 2.2...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.